Tim Buck

Director, Lumasiran Global Marketing at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Tim Buck's Colleagues at Alnylam Pharmaceuticals
Tyler Carlage

Associate Director, Analytical Development

Contact Tyler Carlage

Christopher Weinert

Associate Director - Combination Product

Contact Christopher Weinert

Holly Maier

Director, Regulatory Affairs

Contact Holly Maier

Christopher Fuith

Senior Manager, Medical Device & Combination Product Development

Contact Christopher Fuith

Samuel Rigourd

Senior Director Regulatory Affairs

Contact Samuel Rigourd

Juan Lepe

Senior Director, Procurement R&D and Technology

Contact Juan Lepe

View All Tim Buck's Colleagues
Tim Buck's Contact Details
HQ
(617) 551-8200
Location
Littleton, Massachusetts, United States
Company
Alnylam Pharmaceuticals
Tim Buck's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Tim Buck
Tim Buck currently works for Alnylam Pharmaceuticals.
Tim Buck's role at Alnylam Pharmaceuticals is Director, Lumasiran Global Marketing.
Tim Buck's email address is ***@alnylam.com. To view Tim Buck's full email address, please signup to ConnectPlex.
Tim Buck works in the SaaS industry.
Tim Buck's colleagues at Alnylam Pharmaceuticals are Tyler Carlage, Christopher Weinert, Holly Maier, Chris Sullivan, Christopher Fuith, Samuel Rigourd, Juan Lepe and others.
Tim Buck's phone number is (617) 551-8200
See more information about Tim Buck